Laman UtamaME • NASDAQ
add
23andMe Holding Co.
$4.91
Selepas Waktu Dagangan:(3.87%)+0.19
$5.10
Tutup: 18 Okt, 7:43:49 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$4.91
Julat hari
$4.88 - $5.05
Julat tahun
$4.80 - $20.20
Permodalan pasaran
118.32J USD
Bilangan Purata
224.52K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Jun 2024info | Perubahan T/T |
---|---|---|
Hasil | 40.41J | -33.60% |
Perbelanjaan pengendalian | 92.47J | -31.87% |
Pendapatan bersih | -69.40J | 33.67% |
Margin untung bersih | -171.72 | 0.10% |
Pendapatan bagi setiap syer | -2.42 | 44.16% |
EBITDA | -67.97J | 30.77% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Jun 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 169.97J | -45.93% |
Jumlah aset | 368.05J | -57.75% |
Jumlah liabiliti | 224.54J | 14.73% |
Jumlah ekuiti | 143.50J | — |
Syer tertunggak | 25.30J | — |
Harga kepada buku | 0.87 | — |
Pulangan pada aset | -47.14% | — |
Pulangan pada modal | -74.53% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Jun 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -69.40J | 33.67% |
Tunai daripada operasi | -43.27J | 37.61% |
Tunai daripada pelaburan | -1.16J | 57.11% |
Tunai daripada pembiayaan | 9.00K | 107.89% |
Perubahan bersih dalam tunai | -44.42J | 38.73% |
Aliran tunai bebas | -17.86J | 62.57% |
Perihal
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Diasaskan
Apr 2006
Tapak web
Pekerja
571